These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 6173108)
1. [Effect of interferon on the inhibition of malignant cell growth by human peripheral leukocytes. III. Effect of systemic administration]. Kita M; Imanishi J; Kishida T C R Seances Soc Biol Fil; 1981; 175(6):904-9. PubMed ID: 6173108 [TBL] [Abstract][Full Text] [Related]
2. [Effect of interferon on the inhibition of tumor cell growth by human peripheral leukocytes]. Imanishi J; Kita M; Kishida T; Matsuo A C R Seances Soc Biol Fil; 1980; 173(6):1050-4. PubMed ID: 6155981 [TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes. Lee SH; Kelley S; Chiu H; Stebbing N Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222 [TBL] [Abstract][Full Text] [Related]
6. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta. Jiang H; Lin JJ; Tao J; Fisher PB Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844 [TBL] [Abstract][Full Text] [Related]
7. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients. Koren HS; Brandt CP; Tso CY; Laszlo J J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332 [TBL] [Abstract][Full Text] [Related]
8. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity. Golub SH; D'Amore P; Rainey M J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788 [TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro and systemic effects of native and recombinant interferons-alpha on human natural killer cell cytotoxicity. Edwards BS; Hawkins MJ; Borden EC J Biol Response Mod; 1983; 2(5):409-17. PubMed ID: 6644345 [TBL] [Abstract][Full Text] [Related]
10. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412 [TBL] [Abstract][Full Text] [Related]
11. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786 [TBL] [Abstract][Full Text] [Related]
12. [Effect of interferon on mouse glioma]. Nakagawa Y; Suzuki K; Ibayashi N; Ueda S; Hirakawa K; Oku T; Imanishi J; Kishida T No To Shinkei; 1983 Nov; 35(11):1125-30. PubMed ID: 6197981 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man. Strander H Tex Rep Biol Med; 1977; 35():429-35. PubMed ID: 358466 [TBL] [Abstract][Full Text] [Related]
14. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Borden EC; Hogan TF; Voelkel JG Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598 [TBL] [Abstract][Full Text] [Related]
15. NK cell depletion results in accelerated tumor growth and attenuates the antitumor effect of total body irradiation. Miller GM; Andres ML; Gridley DS Int J Oncol; 2003 Dec; 23(6):1585-92. PubMed ID: 14612930 [TBL] [Abstract][Full Text] [Related]
16. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters. Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270 [TBL] [Abstract][Full Text] [Related]
17. Cationic multilamellar liposome-mediated human interferon-beta gene transfer into cervical cancer cell. Tomoda K; Ohishi N; Kikkawa F; Mizutani S; Tomoda Y; Yagi K Anticancer Res; 1998; 18(3A):1367-71. PubMed ID: 9673342 [TBL] [Abstract][Full Text] [Related]
18. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490 [TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line. Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105 [TBL] [Abstract][Full Text] [Related]
20. [The impairments of natural killer cell activity and interferon response in advanced malignant disease]. Draca S Srp Arh Celok Lek; 1994; 122(1-2):48-50. PubMed ID: 17972805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]